🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEfinopegdutide — what worked for you? Page 3

Efinopegdutide — what worked for you?

marcus_mpls Sun, Aug 4, 2024 at 3:39 PM 14 replies 2,111 viewsPage 3 of 3
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Aug 6, 2024 at 3:03 AM#11
PharmacoVig_BOS said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

22 20emily_PDX, Dr.SleepRoch, laura_annarbor and 19 others
Reply Quote Save Share Report
B12Beth
Member
289
890
Oct 2024
Maryland
Aug 6, 2024 at 5:41 AM#12
laura_annarbor said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Bookmarking. The distinction being drawn above is the one nobody else makes.

23 21carl_compliance, DanielChem_CHI, marco_milano and 20 others
Reply Quote Save Share Report
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Aug 6, 2024 at 8:19 AM#13
PharmacoVig_BOS said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

24 22JessicaH_TX, KevinCompounds, TirzTom and 21 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Aug 6, 2024 at 10:56 AM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Last edited: Aug 6, 2024 at 11:56 AM
25 23cory_ATX, lori_vegas, Dr.PulmRoch and 22 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 6, 2024 at 1:33 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

26 24PurityPaulOR, MaxMetOK, MounjBrad and 23 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register